Literature DB >> 503243

[D-Penacillamine. From constituent of penicillins to significant drug].

E Lodemann.   

Abstract

D-Penicillamine is used against a variety of diseases. For many years it has been successful in treating Wilson's disease, cystinuria and heavy-metal poisonings. It also proved to be effective against rheumatoid arthritis, scleroderma, chronic active hepatitis, pulmonary fibrosis and multiple sclerosis. However, the use of D-penicillamine is still limited owing to the frequent occurrence of considerable, though generally reversible, side effects. This article deals with the history of D-penicillamine as well as the methods of its synthesis, its pharmacokinetics, effects and side effects. In addition, the significance of the stereo isomeric L-penicillamine is discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 503243     DOI: 10.1007/bf00399003

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  40 in total

1.  Pregnancy in penicillamine-treated patients with Wilson's disease.

Authors:  I H Scheinberg; I Sternlieb
Journal:  N Engl J Med       Date:  1975-12-18       Impact factor: 91.245

2.  METAL CHELATES OF SOME SULFUR-CONTAINING AMINO ACIDS.

Authors:  G R LENZ; A E MARTELL
Journal:  Biochemistry       Date:  1964-06       Impact factor: 3.162

3.  Intra-articular dissociation of the rheumatoid factor.

Authors:  I A JAFFE
Journal:  J Lab Clin Med       Date:  1962-09

4.  Penicillamine, a new oral therapy for Wilson's disease.

Authors:  J M WALSHE
Journal:  Am J Med       Date:  1956-10       Impact factor: 4.965

5.  [Action mechanism of antibiotics and their effect on growth of animals. I. Tests with penicillin].

Authors:  A WACKER; W HEYL; H BUECHL; H J HOLTHOFF
Journal:  Arzneimittelforschung       Date:  1955-12

6.  D-penicillamine therapy of acute arsenic poisoning.

Authors:  R G Peterson; B H Rumack
Journal:  J Pediatr       Date:  1977-10       Impact factor: 4.406

7.  Studies with 35S-labelled DL-penicillamine in patients with Wilson's disease.

Authors:  K Gibbs; J M Walshe
Journal:  Q J Med       Date:  1971-04

8.  [The mesenchyma suppressive effect of D-penicillamine].

Authors:  U S Müller; H Wagner; W Wirth; G Junge-Hülsing; W H Hauss
Journal:  Arzneimittelforschung       Date:  1971-05

9.  Neonatal abnormalities associated with D-penicillamine treatment during pregnancy.

Authors:  L Solomon; G Abrams; M Dinner; L Berman
Journal:  N Engl J Med       Date:  1977-01-06       Impact factor: 91.245

10.  Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis.

Authors:  Y Shiokawa; Y Horiuchi; M Honma; T Kageyama; T Okada; T Azuma
Journal:  Arthritis Rheum       Date:  1977 Nov-Dec
View more
  1 in total

1.  Isolation of the first crystalline D-penicillamine complex of iron and some remarks on relevant aspects of metal-chelating drugs as well as metabolism disorders.

Authors:  A Müller; M Straube; E Krickemeyer; H Bögge
Journal:  Naturwissenschaften       Date:  1992-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.